About OraSure Technologies
OraSure Technologies is a company based in Bethlehem (United States) founded in 1987. It operates as a Direct-to-Consumer (D2C), Reseller / Distribution, and HealthTech. The company has 501 employees as of December 31, 2024. OraSure Technologies has completed 6 acquisitions, including CoreBiome, DNA Genotek and Diversigen. OraSure Technologies offers products and services including Rapid Diagnostic Tests and Sample Collection Devices. OraSure Technologies operates in a competitive market with competitors including Souzhou Ribo Life Science, PathoQuest, Quantalife, Senzo and Hememics Biotechnologies, among others.
- Headquarter Bethlehem, United States
- Employees 501 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Orasure Technologies, Inc.
-
Annual Revenue
$185.83 M (USD)-54.17as on Dec 31, 2024
-
Net Profit
-$19.5 M (USD)-136.34as on Dec 31, 2024
-
EBITDA
-$9.73 M (USD)-113.15as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Gates Foundation
& 2 more
-
Employee Count
501
as on Dec 31, 2024
-
Investments & Acquisitions
CoreBiome
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of OraSure Technologies
OraSure Technologies is a publicly listed company on the NASDAQ with ticker symbol OSUR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of OraSure Technologies
OraSure Technologies offers a comprehensive portfolio of products and services, including Rapid Diagnostic Tests and Sample Collection Devices.
Rapid tests for detecting critical medical conditions are provided.
Devices for sample collection and stabilization are offered globally.
People of OraSure Technologies
Unlock access to complete
Unlock access to complete
Leadership Team
24 people
Sales and Marketing
12 people
Senior Team
9 people
Software Development Team
9 people
Product Management Team
7 people
Finance and Accounting
7 people
Operations Team
4 people
Human Resources and Administration
4 people
Unlock access to complete
Funding Insights of OraSure Technologies
Investors in OraSure Technologies
OraSure Technologies has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gates Foundation, HHS and Public Health Emergency.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for OraSure Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OraSure Technologies
OraSure Technologies has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include CoreBiome, DNA Genotek and Diversigen.
Investment portfolio details for OraSure Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Sherlock Biosciences is focused on molecular diagnostics development.
|
Locked | Locked | 2019 | Locked | |
|
Microbiome diversity is analyzed using big data methods.
|
Locked | Locked | 2016 | Locked | |
|
Non-invasive urine test for HIV PrEP adherence monitoring is developed.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for OraSure Technologies
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - OraSure Technologies
Detailed financials for OraSure Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orasure Technologies Comparisons
Peer comparison for OraSure Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OraSure Technologies
OraSure Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, PathoQuest, Quantalife, Senzo and Hememics Biotechnologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| Locked | Locked | Locked |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| Locked | Locked | Locked |
Point of care diagnostic platform and data management system
|
Detailed competitors of OraSure Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orasure Technologies
Complete news archive for OraSure Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OraSure Technologies
OraSure Technologies was founded in 1987 and raised its 1st funding round 25 years after it was founded.
OraSure Technologies is headquartered in Bethlehem, United States.
Douglas A. Michels is the current CEO of OraSure Technologies.
As of Dec 31, 2024, the latest employee count at OraSure Technologies is 501.
Annual revenue of OraSure Technologies is $185.83M as on Dec 31, 2024.
OraSure Technologies, Inc. is involved in the development, manufacture, and distribution of rapid diagnostic tests and sample collection solutions. The company operates within the healthcare sector, focusing on improving access, quality, and value of medical services. Products are distributed globally to clinical laboratories, hospitals, clinics, public health organizations, and direct to consumers. Subsidiaries like DNA Genotek and Sherlock Biosciences contribute to innovative solutions for detecting critical medical conditions such as HIV, HCV, and syphilis.
OraSure Technologies's top competitors include Souzhou Ribo Life Science, Quantalife and Senzo.
OraSure Technologies offers Rapid Diagnostic Tests and Sample Collection Devices.
Yes, OraSure Technologies is publicly traded on NASDAQ under the ticker symbol OSUR.
OraSure Technologies has made 6 acquisitions, including CoreBiome, DNA Genotek, and Diversigen.
OraSure Technologies has 3 investors. Key investors include Gates Foundation, HHS, and Public Health Emergency.
The ticker symbol of OraSure Technologies is OSUR on NASDAQ.